Innovent Biologics, Inc. (HKG:1801)
Hong Kong
· Delayed Price · Currency is HKD 41.70
+2.40 (6.11%)
Feb 21, 2025, 4:08 PM HKT
Innovent Biologics Market Cap
Innovent Biologics has a market cap or net worth of 68.31 billion as of February 21, 2025. Its market cap has increased by 26.30% in one year.
Market Cap
68.31B
Enterprise Value
62.64B
Revenue
8.01B
Ranking
n/a
PE Ratio
n/a
Stock Price
41.70
Market Cap Chart
Since October 31, 2018, Innovent Biologics's market cap has increased from 18.54B to 68.31B, an increase of 268.48%. That is a compound annual growth rate of 22.94%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeiGene | 211.72B |
| JD Health International | 117.55B |
| Hansoh Pharmaceutical Group Company | 117.50B |
| WuXi Biologics | 106.51B |
| Alibaba Health Information Technology | 97.13B |
| Akeso | 61.89B |
| Sinopharm Group | 61.79B |
| Sino Biopharmaceutical | 60.73B |